Roberta Paolillo

7PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 15, 2026
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study.

Giuseppe Gargiulo, Viviana Narciso, Imma Forzano

|Feb 13, 2026
Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention.

Imma Forzano, Viviana Narciso, Mario Enrico Canonico

|Dec 11, 2025
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention.

Imma Forzano, Domenico Florimonte, Viviana Narciso

|Apr 25, 2025
Procedural and Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Narrative Review.

Domenico Simone Castiello, Federica Buongiorno, Lina Manzi

|Mar 13, 2025
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal.

Lina Manzi, Federica Buongiorno, Viviana Narciso

|Jul 18, 2024
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial.

Raffaele Piccolo, Fiorenzo Simonetti, Marisa Avvedimento

Pageof 2